Burzynski Research Institute, Inc. (BZYR)

Market Cap	4.60M
Revenue (ttm)	n/a
Net Income (ttm)	-1.46M
Shares Out	131.45M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,564
Average Volume	2,721
Open	0.0390
Previous Close	0.0350
Day's Range	0.0350 - 0.0540
52-Week Range	0.0301 - 0.0770
Beta	2.03
RSI	42.68
Earnings Date	May 27, 2025

About BZYR

Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. The company was incorporated in 1984 and is headquartered in Houston, Texas.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1984
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: BZYR